HEADER PROTEIN FIBRIL 03-MAR-22 7Z40 OBSLTE 15-MAR-23 7Z40 8ADE TITLE WILD TYPE ATTR AMYLOID FIBRIL FROM SENILE SYSTEMIC AMYLOIDOSIS COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSTHYRETIN; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 SYNONYM: ATTR,PREALBUMIN,TBPA SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606 KEYWDS TRANSTHYRETIN AMYLIOD FIBRIL, PROTEIN FIBRIL EXPDTA ELECTRON MICROSCOPY AUTHOR M.SCHMIDT,M.STEINEBREI REVDAT 2 15-MAR-23 7Z40 1 OBSLTE REVDAT 1 18-JAN-23 7Z40 0 JRNL AUTH M.STEINEBREI,J.GOTTWALD,J.BAUR,C.ROCKEN,U.HEGENBART, JRNL AUTH 2 S.SCHONLAND,M.SCHMIDT JRNL TITL CRYO-EM STRUCTURE OF AN ATTRWT AMYLOID FIBRIL FROM SYSTEMIC JRNL TITL 2 NON-HEREDITARY TRANSTHYRETIN AMYLOIDOSIS. JRNL REF NAT COMMUN V. 13 6398 2022 JRNL REFN ESSN 2041-1723 JRNL PMID 36302762 JRNL DOI 10.1038/S41467-022-33591-4 REMARK 2 REMARK 2 RESOLUTION. 2.78 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : RELION, CTFFIND REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.780 REMARK 3 NUMBER OF PARTICLES : 70624 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7Z40 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 5 REMARK 5 OBSOLETE REQUEST: 2023-03-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-MAR-22. REMARK 100 THE DEPOSITION ID IS D_1292120795. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : HELICAL REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : HELICAL ARRAY REMARK 245 PARTICLE TYPE : HELICAL REMARK 245 NAME OF SAMPLE : TRANSTHYRETIN AMYOLID FIBRILS REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.00 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 QUANTUM (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2500.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 4490.00 REMARK 245 ILLUMINATION MODE : SPOT SCAN REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 PRO A 2 REMARK 465 THR A 3 REMARK 465 GLY A 4 REMARK 465 THR A 5 REMARK 465 GLY A 6 REMARK 465 GLU A 7 REMARK 465 SER A 8 REMARK 465 LYS A 9 REMARK 465 CYS A 10 REMARK 465 ALA A 36 REMARK 465 ALA A 37 REMARK 465 ASP A 38 REMARK 465 ASP A 39 REMARK 465 THR A 40 REMARK 465 TRP A 41 REMARK 465 GLU A 42 REMARK 465 PRO A 43 REMARK 465 PHE A 44 REMARK 465 ALA A 45 REMARK 465 SER A 46 REMARK 465 GLY A 47 REMARK 465 LYS A 48 REMARK 465 THR A 49 REMARK 465 SER A 50 REMARK 465 GLU A 51 REMARK 465 SER A 52 REMARK 465 GLY A 53 REMARK 465 GLU A 54 REMARK 465 LEU A 55 REMARK 465 HIS A 56 REMARK 465 ASN A 124 REMARK 465 PRO A 125 REMARK 465 LYS A 126 REMARK 465 GLU A 127 REMARK 465 GLY B 1 REMARK 465 PRO B 2 REMARK 465 THR B 3 REMARK 465 GLY B 4 REMARK 465 THR B 5 REMARK 465 GLY B 6 REMARK 465 GLU B 7 REMARK 465 SER B 8 REMARK 465 LYS B 9 REMARK 465 CYS B 10 REMARK 465 ALA B 36 REMARK 465 ALA B 37 REMARK 465 ASP B 38 REMARK 465 ASP B 39 REMARK 465 THR B 40 REMARK 465 TRP B 41 REMARK 465 GLU B 42 REMARK 465 PRO B 43 REMARK 465 PHE B 44 REMARK 465 ALA B 45 REMARK 465 SER B 46 REMARK 465 GLY B 47 REMARK 465 LYS B 48 REMARK 465 THR B 49 REMARK 465 SER B 50 REMARK 465 GLU B 51 REMARK 465 SER B 52 REMARK 465 GLY B 53 REMARK 465 GLU B 54 REMARK 465 LEU B 55 REMARK 465 HIS B 56 REMARK 465 ASN B 124 REMARK 465 PRO B 125 REMARK 465 LYS B 126 REMARK 465 GLU B 127 REMARK 465 GLY C 1 REMARK 465 PRO C 2 REMARK 465 THR C 3 REMARK 465 GLY C 4 REMARK 465 THR C 5 REMARK 465 GLY C 6 REMARK 465 GLU C 7 REMARK 465 SER C 8 REMARK 465 LYS C 9 REMARK 465 CYS C 10 REMARK 465 ALA C 36 REMARK 465 ALA C 37 REMARK 465 ASP C 38 REMARK 465 ASP C 39 REMARK 465 THR C 40 REMARK 465 TRP C 41 REMARK 465 GLU C 42 REMARK 465 PRO C 43 REMARK 465 PHE C 44 REMARK 465 ALA C 45 REMARK 465 SER C 46 REMARK 465 GLY C 47 REMARK 465 LYS C 48 REMARK 465 THR C 49 REMARK 465 SER C 50 REMARK 465 GLU C 51 REMARK 465 SER C 52 REMARK 465 GLY C 53 REMARK 465 GLU C 54 REMARK 465 LEU C 55 REMARK 465 HIS C 56 REMARK 465 ASN C 124 REMARK 465 PRO C 125 REMARK 465 LYS C 126 REMARK 465 GLU C 127 REMARK 465 GLY D 1 REMARK 465 PRO D 2 REMARK 465 THR D 3 REMARK 465 GLY D 4 REMARK 465 THR D 5 REMARK 465 GLY D 6 REMARK 465 GLU D 7 REMARK 465 SER D 8 REMARK 465 LYS D 9 REMARK 465 CYS D 10 REMARK 465 ALA D 36 REMARK 465 ALA D 37 REMARK 465 ASP D 38 REMARK 465 ASP D 39 REMARK 465 THR D 40 REMARK 465 TRP D 41 REMARK 465 GLU D 42 REMARK 465 PRO D 43 REMARK 465 PHE D 44 REMARK 465 ALA D 45 REMARK 465 SER D 46 REMARK 465 GLY D 47 REMARK 465 LYS D 48 REMARK 465 THR D 49 REMARK 465 SER D 50 REMARK 465 GLU D 51 REMARK 465 SER D 52 REMARK 465 GLY D 53 REMARK 465 GLU D 54 REMARK 465 LEU D 55 REMARK 465 HIS D 56 REMARK 465 ASN D 124 REMARK 465 PRO D 125 REMARK 465 LYS D 126 REMARK 465 GLU D 127 REMARK 465 GLY E 1 REMARK 465 PRO E 2 REMARK 465 THR E 3 REMARK 465 GLY E 4 REMARK 465 THR E 5 REMARK 465 GLY E 6 REMARK 465 GLU E 7 REMARK 465 SER E 8 REMARK 465 LYS E 9 REMARK 465 CYS E 10 REMARK 465 ALA E 36 REMARK 465 ALA E 37 REMARK 465 ASP E 38 REMARK 465 ASP E 39 REMARK 465 THR E 40 REMARK 465 TRP E 41 REMARK 465 GLU E 42 REMARK 465 PRO E 43 REMARK 465 PHE E 44 REMARK 465 ALA E 45 REMARK 465 SER E 46 REMARK 465 GLY E 47 REMARK 465 LYS E 48 REMARK 465 THR E 49 REMARK 465 SER E 50 REMARK 465 GLU E 51 REMARK 465 SER E 52 REMARK 465 GLY E 53 REMARK 465 GLU E 54 REMARK 465 LEU E 55 REMARK 465 HIS E 56 REMARK 465 ASN E 124 REMARK 465 PRO E 125 REMARK 465 LYS E 126 REMARK 465 GLU E 127 REMARK 465 GLY F 1 REMARK 465 PRO F 2 REMARK 465 THR F 3 REMARK 465 GLY F 4 REMARK 465 THR F 5 REMARK 465 GLY F 6 REMARK 465 GLU F 7 REMARK 465 SER F 8 REMARK 465 LYS F 9 REMARK 465 CYS F 10 REMARK 465 ALA F 36 REMARK 465 ALA F 37 REMARK 465 ASP F 38 REMARK 465 ASP F 39 REMARK 465 THR F 40 REMARK 465 TRP F 41 REMARK 465 GLU F 42 REMARK 465 PRO F 43 REMARK 465 PHE F 44 REMARK 465 ALA F 45 REMARK 465 SER F 46 REMARK 465 GLY F 47 REMARK 465 LYS F 48 REMARK 465 THR F 49 REMARK 465 SER F 50 REMARK 465 GLU F 51 REMARK 465 SER F 52 REMARK 465 GLY F 53 REMARK 465 GLU F 54 REMARK 465 LEU F 55 REMARK 465 HIS F 56 REMARK 465 ASN F 124 REMARK 465 PRO F 125 REMARK 465 LYS F 126 REMARK 465 GLU F 127 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 25 112.77 -166.61 REMARK 500 ALA B 25 112.73 -166.71 REMARK 500 ALA C 25 112.77 -166.61 REMARK 500 ALA D 25 112.63 -166.67 REMARK 500 ALA E 25 112.80 -166.65 REMARK 500 ALA F 25 112.77 -166.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-14482 RELATED DB: EMDB REMARK 900 WILD TYPE ATTR AMYLOID FIBRIL FROM SENILE SYSTEMIC AMYLOIDOSIS DBREF 7Z40 A 1 127 UNP P02766 TTHY_HUMAN 21 147 DBREF 7Z40 B 1 127 UNP P02766 TTHY_HUMAN 21 147 DBREF 7Z40 C 1 127 UNP P02766 TTHY_HUMAN 21 147 DBREF 7Z40 D 1 127 UNP P02766 TTHY_HUMAN 21 147 DBREF 7Z40 E 1 127 UNP P02766 TTHY_HUMAN 21 147 DBREF 7Z40 F 1 127 UNP P02766 TTHY_HUMAN 21 147 SEQRES 1 A 127 GLY PRO THR GLY THR GLY GLU SER LYS CYS PRO LEU MET SEQRES 2 A 127 VAL LYS VAL LEU ASP ALA VAL ARG GLY SER PRO ALA ILE SEQRES 3 A 127 ASN VAL ALA VAL HIS VAL PHE ARG LYS ALA ALA ASP ASP SEQRES 4 A 127 THR TRP GLU PRO PHE ALA SER GLY LYS THR SER GLU SER SEQRES 5 A 127 GLY GLU LEU HIS GLY LEU THR THR GLU GLU GLU PHE VAL SEQRES 6 A 127 GLU GLY ILE TYR LYS VAL GLU ILE ASP THR LYS SER TYR SEQRES 7 A 127 TRP LYS ALA LEU GLY ILE SER PRO PHE HIS GLU HIS ALA SEQRES 8 A 127 GLU VAL VAL PHE THR ALA ASN ASP SER GLY PRO ARG ARG SEQRES 9 A 127 TYR THR ILE ALA ALA LEU LEU SER PRO TYR SER TYR SER SEQRES 10 A 127 THR THR ALA VAL VAL THR ASN PRO LYS GLU SEQRES 1 B 127 GLY PRO THR GLY THR GLY GLU SER LYS CYS PRO LEU MET SEQRES 2 B 127 VAL LYS VAL LEU ASP ALA VAL ARG GLY SER PRO ALA ILE SEQRES 3 B 127 ASN VAL ALA VAL HIS VAL PHE ARG LYS ALA ALA ASP ASP SEQRES 4 B 127 THR TRP GLU PRO PHE ALA SER GLY LYS THR SER GLU SER SEQRES 5 B 127 GLY GLU LEU HIS GLY LEU THR THR GLU GLU GLU PHE VAL SEQRES 6 B 127 GLU GLY ILE TYR LYS VAL GLU ILE ASP THR LYS SER TYR SEQRES 7 B 127 TRP LYS ALA LEU GLY ILE SER PRO PHE HIS GLU HIS ALA SEQRES 8 B 127 GLU VAL VAL PHE THR ALA ASN ASP SER GLY PRO ARG ARG SEQRES 9 B 127 TYR THR ILE ALA ALA LEU LEU SER PRO TYR SER TYR SER SEQRES 10 B 127 THR THR ALA VAL VAL THR ASN PRO LYS GLU SEQRES 1 C 127 GLY PRO THR GLY THR GLY GLU SER LYS CYS PRO LEU MET SEQRES 2 C 127 VAL LYS VAL LEU ASP ALA VAL ARG GLY SER PRO ALA ILE SEQRES 3 C 127 ASN VAL ALA VAL HIS VAL PHE ARG LYS ALA ALA ASP ASP SEQRES 4 C 127 THR TRP GLU PRO PHE ALA SER GLY LYS THR SER GLU SER SEQRES 5 C 127 GLY GLU LEU HIS GLY LEU THR THR GLU GLU GLU PHE VAL SEQRES 6 C 127 GLU GLY ILE TYR LYS VAL GLU ILE ASP THR LYS SER TYR SEQRES 7 C 127 TRP LYS ALA LEU GLY ILE SER PRO PHE HIS GLU HIS ALA SEQRES 8 C 127 GLU VAL VAL PHE THR ALA ASN ASP SER GLY PRO ARG ARG SEQRES 9 C 127 TYR THR ILE ALA ALA LEU LEU SER PRO TYR SER TYR SER SEQRES 10 C 127 THR THR ALA VAL VAL THR ASN PRO LYS GLU SEQRES 1 D 127 GLY PRO THR GLY THR GLY GLU SER LYS CYS PRO LEU MET SEQRES 2 D 127 VAL LYS VAL LEU ASP ALA VAL ARG GLY SER PRO ALA ILE SEQRES 3 D 127 ASN VAL ALA VAL HIS VAL PHE ARG LYS ALA ALA ASP ASP SEQRES 4 D 127 THR TRP GLU PRO PHE ALA SER GLY LYS THR SER GLU SER SEQRES 5 D 127 GLY GLU LEU HIS GLY LEU THR THR GLU GLU GLU PHE VAL SEQRES 6 D 127 GLU GLY ILE TYR LYS VAL GLU ILE ASP THR LYS SER TYR SEQRES 7 D 127 TRP LYS ALA LEU GLY ILE SER PRO PHE HIS GLU HIS ALA SEQRES 8 D 127 GLU VAL VAL PHE THR ALA ASN ASP SER GLY PRO ARG ARG SEQRES 9 D 127 TYR THR ILE ALA ALA LEU LEU SER PRO TYR SER TYR SER SEQRES 10 D 127 THR THR ALA VAL VAL THR ASN PRO LYS GLU SEQRES 1 E 127 GLY PRO THR GLY THR GLY GLU SER LYS CYS PRO LEU MET SEQRES 2 E 127 VAL LYS VAL LEU ASP ALA VAL ARG GLY SER PRO ALA ILE SEQRES 3 E 127 ASN VAL ALA VAL HIS VAL PHE ARG LYS ALA ALA ASP ASP SEQRES 4 E 127 THR TRP GLU PRO PHE ALA SER GLY LYS THR SER GLU SER SEQRES 5 E 127 GLY GLU LEU HIS GLY LEU THR THR GLU GLU GLU PHE VAL SEQRES 6 E 127 GLU GLY ILE TYR LYS VAL GLU ILE ASP THR LYS SER TYR SEQRES 7 E 127 TRP LYS ALA LEU GLY ILE SER PRO PHE HIS GLU HIS ALA SEQRES 8 E 127 GLU VAL VAL PHE THR ALA ASN ASP SER GLY PRO ARG ARG SEQRES 9 E 127 TYR THR ILE ALA ALA LEU LEU SER PRO TYR SER TYR SER SEQRES 10 E 127 THR THR ALA VAL VAL THR ASN PRO LYS GLU SEQRES 1 F 127 GLY PRO THR GLY THR GLY GLU SER LYS CYS PRO LEU MET SEQRES 2 F 127 VAL LYS VAL LEU ASP ALA VAL ARG GLY SER PRO ALA ILE SEQRES 3 F 127 ASN VAL ALA VAL HIS VAL PHE ARG LYS ALA ALA ASP ASP SEQRES 4 F 127 THR TRP GLU PRO PHE ALA SER GLY LYS THR SER GLU SER SEQRES 5 F 127 GLY GLU LEU HIS GLY LEU THR THR GLU GLU GLU PHE VAL SEQRES 6 F 127 GLU GLY ILE TYR LYS VAL GLU ILE ASP THR LYS SER TYR SEQRES 7 F 127 TRP LYS ALA LEU GLY ILE SER PRO PHE HIS GLU HIS ALA SEQRES 8 F 127 GLU VAL VAL PHE THR ALA ASN ASP SER GLY PRO ARG ARG SEQRES 9 F 127 TYR THR ILE ALA ALA LEU LEU SER PRO TYR SER TYR SER SEQRES 10 F 127 THR THR ALA VAL VAL THR ASN PRO LYS GLU SHEET 1 AA1 6 VAL A 28 ARG A 34 0 SHEET 2 AA1 6 VAL B 28 ARG B 34 1 O ALA B 29 N VAL A 30 SHEET 3 AA1 6 VAL C 28 ARG C 34 1 O ALA C 29 N VAL B 30 SHEET 4 AA1 6 VAL D 28 ARG D 34 1 O ALA D 29 N VAL C 30 SHEET 5 AA1 6 VAL E 28 ARG E 34 1 O ALA E 29 N VAL D 30 SHEET 6 AA1 6 VAL F 28 ARG F 34 1 O ALA F 29 N VAL E 30 SHEET 1 AA2 6 VAL A 65 GLU A 66 0 SHEET 2 AA2 6 VAL B 65 GLU B 66 1 O VAL B 65 N GLU A 66 SHEET 3 AA2 6 VAL C 65 GLU C 66 1 O VAL C 65 N GLU B 66 SHEET 4 AA2 6 VAL D 65 GLU D 66 1 O VAL D 65 N GLU C 66 SHEET 5 AA2 6 VAL E 65 GLU E 66 1 O VAL E 65 N GLU D 66 SHEET 6 AA2 6 VAL F 65 GLU F 66 1 O VAL F 65 N GLU E 66 SHEET 1 AA3 6 ARG A 104 TYR A 105 0 SHEET 2 AA3 6 ARG B 104 TYR B 105 1 O TYR B 105 N ARG A 104 SHEET 3 AA3 6 ARG C 104 TYR C 105 1 O TYR C 105 N ARG B 104 SHEET 4 AA3 6 ARG D 104 TYR D 105 1 O TYR D 105 N ARG C 104 SHEET 5 AA3 6 ARG E 104 TYR E 105 1 O TYR E 105 N ARG D 104 SHEET 6 AA3 6 ARG F 104 TYR F 105 1 O TYR F 105 N ARG E 104 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000